Martina Bazzaro, PhD - University of Minnesota - Twin Cities Campus
Ronny Drapkin, MD, PhD - University of Pennsylvania - Perelman School of Medicine
Melissa Geller, MD, MS - University of Minnesota - Twin Cities Campus
Andrew Godwin, PhD - University of Kansas - Kansas City
Gottfried E. Konecny, MD - University of California - Los Angeles
Boris Winterhoff, MD - University of Minnesota - Twin Cities Campus

The 2022 Ovarian Cancer Midwest Focus (OCMF) Conference will be both an in-person and a virtual conference that will include live streamed discussion rounds with national and international speakers, short talks based on abstracts, and group discussions. Topics will include Early Detection, Immunotherapy, Novel Therapeutics, Metabolism, Preclinical Models of Ovarian Cancer, Personalized Medicine, Microenvironment, Epigenetics, PARP Inhibitors, Chemoresistance, Combination Therapy, Clinical Studies, Technology Commercialization, and Career Development (lunch and learn).

The Symposium will begin virtually and in-person on Thursday morning. The conference is single-track (no concurrent sessions) to give all attendees the opportunity to hear all presentations and discussions. Each day will feature Keynote Speakers, Flash Talks, and Lunch and Learn Presentations.

Click here for more information.

Oral presentations are 5 minutes in length and are given in a plenary format to an interdisciplinary audience of approximately 100 attendees. Hence, the content should be interesting to a diverse audience and clearly focused to deliver two or three key points.

This conference aims to provide a collaborative environment which will allow an interdisciplinary approach to ovarian cancer research; a broad range of topics will be covered that address topic areas related to ovarian cancer research, including:

- Chemoresistance -
- Clinical Studies -
- Combination Therapy -
- Early detection -
- Epigenetics -
- Immunotherapy -
- Metabolism -
- Microenvironment -
- Novel Therapeutics -
- PARP Inhibitors -
- Personalized medicine -
- Preclinical models of ovarian cancer -

The deadline for oral presentation proposals is October 14, 2022.

ABSTRACT SUBMISSION

Follow this link to submit a session proposal for oral presentation abstract.